Table 1.
Treatment Groups | Day 1 Average Weight (g, n=8) |
Day 21 Average Weight (g, n=8) |
Weight Gain (+)/Loss (−) (g) |
---|---|---|---|
Control | 23.04 ± 1.77 | 26.58 ± 1.74 | +3.55 ± 0.94 |
Mn | 19.54 ± 3.47 | 18.11 ± 2.06 | −1.43 ± 2.02 |
VPA | 22.58 ± 1.27 | 24.60 ± 1.82 | +2.03 ± 1.16 |
VPA + Mn | 21.99 ± 0.85 | 22.02 ± 0.99 | +0.03 ± 0.43 |
NaB | 22.48 ± 1.19 | 23.45 ± 1.65 | +0.97 ± 1.37 |
NaB + Mn | 21.90 ± 1.73 | 20.07 ± 1.41 | −1.83 ± 0.44 |
Mice were pretreated with VPA (100 μl/200 mg/kg, i.p. daily) or with NaB (100 μl/1200 mg/kg, i.p. daily) 30 min prior to Mn exposure (2 μl/30mg/kg, intranasal instillation, daily) for consecutive 21 days. Body weights were measured throughout the experiment and weight gain recorded on day 1 and day 21. Results represent mean ± S.E.M derived from eight independent experiments and each of their weights are expressed in grams (g). Statistical analysis was performed by two-way ANOVA repeated measures, followed by Tukey’s post-hoc test, (n=8).